PLoS ONE (Jan 2022)

COVID-19 vaccine acceptance among pregnant women worldwide: A systematic review and meta-analysis.

  • Milad Azami,
  • Marzieh Parizad Nasirkandy,
  • Hadi Esmaeili Gouvarchin Ghaleh,
  • Reza Ranjbar

DOI
https://doi.org/10.1371/journal.pone.0272273
Journal volume & issue
Vol. 17, no. 9
p. e0272273

Abstract

Read online

BackgroundThe COVID-19 pandemic has led to the death of many people worldwide. The World Health Organization (WHO) has declared vaccine resistance as one of the greatest health threats in the world even before the COVID-19 epidemic. The aim of this study was to evaluate the acceptance of COVID-19 vaccine in pregnant women.MethodWe performed this systematic review and meta-analysis in accordance with the PRISMA guidelines. We applied the standard search strategy to the PubMed/Medline, Web of Science (ISI), Scopus, Science Direct, Cochrane Library, EMBASE, and EBSCO databases, and the Google Scholar search engine. Heterogeneity between studies was relatively high and therefore meta-analyses were performed based on random effects model with 95% CI using STATA version 16.ResultsIn 16 articles with a sample size of 19219 pregnant women, the acceptance of COVID-19 vaccine was estimated 53.46% (95%CI: 47.64%-59.24%). Subgroup analysis was performed based on continent (p = 0.796), data collection method (p = 0.450) and meta-regression based on the month of the study (PConclusionThe prevalence of COVID-19 vaccine acceptance in pregnant women was 53.46%, which was much lower than the general COVID-19 vaccination. Therefore, necessary interventions should be taken to increase the acceptance of the vaccine, address safety concerns and educate about it.